Skip to content

Clinical trials

Terminated Lung Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Terminated Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20152
20171
20204
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology1
BeOne Medicines1
Bristol-Myers Squibb1
Elevation Oncology1
Fusion Pharmaceuticals Inc.1
Hanmi Pharmaceutical Company Limited1
Hoffmann-La Roche1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung8
Neoplasm Metastasis5
Head and Neck Neoplasms4
Colorectal Neoplasms3
Ovarian Neoplasms3
Adenocarcinoma of Lung2
Breast Neoplasms2
Neoplasms2
Sarcoma2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.